Changes of Cytokine Level in Patients with Hypertension and Obesity, Depending on the Duration of the Disease
Journal Title: Міжнародний ендокринологічний журнал - Year 2016, Vol 8, Issue 80
Abstract
Interleukins (IL) 2, 6, 10, and C-reactive protein are crucial in arterial hypertension with obesity. Background. To identify the characteristics of inflammatory markers in patients with arterial hypertension and obesity, in accordance with the disease duration. Materials and Methods. The study involved 52 patients with stage II hypertension and obesity, divided in three groups according to the disease duration. In the first group consisted of 19 patients disease duration was 5 years, in the second (18 patients) — 6–10 years, and in the third one (15 patients) — more than 11 years. The serum levels of inflammatory markers were determined by ELISA. Results. When disease duration is 6–10 years, the IL‑6 level is increased slightly compared to the first group, and then decreased. The content of IL‑2 was increased in the first group by 3.74 times, and further decreased by 3.15 times and 3.04 times, respectively, compared to the controls. Levels of IL‑10 and C-reactive protein have the same tendency, as IL‑6. Conclusions. It was found that levels of interleukin 2, 6, 10, and C-reactive protein are significantly increased in patients with hypertension and obesity (greater levels of pro-inflammatory cytokines than the anti-inflammatory). Lengthening the duration of illness leads to less expressive inflammation that may indicate deeper immunological disorders. Initially increased blood concentration of cytokines and C-reactive protein became significantly reduced under standard therapy, but not significantly different from the controls, except the level of IL‑2.
Authors and Affiliations
V. A. Kapustnik, I. F. Kostyuk, В. О. Shelest, J. O. Кovalyova
Keywords
Related Articles
- EP ID EP177077
- DOI 10.22141/2224-0721.8.80.2016.89537
- Views 60
- Downloads 0
Clinical experience of using herbal medicinal product Glucemedin in the comprehensive treatment of patients with type 2 diabetes mellitus
Background. The current task of treating patients with type 2 diabetes mellitus and dyslipoproteinemia is the analysis of efficiency of the combination of standard hypoglycemic agents with phytotherapeutic drugs, but inf...
Role of Underweight and Overweight in the Development of Vertebral Pain Syndrome in Systemic Osteoporosis
A well-known risk factor for osteoporosis and fractures is weight, so its derivative — body mass index (BMI) — has been added to FRAX model. Numerous studies have shown a correlation between body mass index and risk of f...
News of Practical Endocrinology Following the Results of the Congress of the European Society of Endocrinology 2016
The review was made of the reports submitted in the framework of the event from the series «Endocrinology Board», held on November 23, 2016 in Kyiv, Ukraine.
Immunological indicators in children with different types of obesity
Background. To date, numerous prospective studies convincingly indicate a direct correlation of obesity with an increased risk of life-threatening diseases. It is important that over 60 % of patients has childhood-onset...
Calcification and Apoptosis of Blood Cells as a Marker of the Presence, Severity and Progression of Coronary Heart Disease Associated with Type 2 Diabetes Mellitus: Ultrastructural and Cytological Studies
Background. The increase of intercellular content of Ca2+ leads to the initiation of apoptosis processes and calcification of the cells of the blood and cardiovascular system. The close relationship between the apoptosis...